US2432049A - Cholinelike compounds - Google Patents

Cholinelike compounds Download PDF

Info

Publication number
US2432049A
US2432049A US613964A US61396445A US2432049A US 2432049 A US2432049 A US 2432049A US 613964 A US613964 A US 613964A US 61396445 A US61396445 A US 61396445A US 2432049 A US2432049 A US 2432049A
Authority
US
United States
Prior art keywords
ethyl
ether
gms
butyl
carbamate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US613964A
Inventor
Kenneth C Swan
Norman G White
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US613964A priority Critical patent/US2432049A/en
Application granted granted Critical
Publication of US2432049A publication Critical patent/US2432049A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids

Definitions

  • R is selected from the group consisting of lower alkyl radicals; X is an anion; R is selected from the group consisting of hydrogen and lower alkyl radicals; and R" is selected from the wherein'the substituents R. are the same and of the class consisting of lower alkyl'radicals, R1 is of the class consisting of H and lower alkyl radicals different from the substituents R, R2 is of the class consisting of alkyl radicals of at least four carbon atoms and aryl radicals, R3 is of the class consisting of H and lower alkyl radicals, and X is an anion.
  • the compounds of our invention in which the hydrogens attached to the nitrogen of the carbamate group are recontinuation-in-part of i placed by small polar groups, that is, radicals containing less than four carbon atoms, produce constriction of the pupil and contraction of the ciliary muscle when administered to individuals, the compounds of our invention, in which the hydrogens attached to the nitrogen of the carbamate group are replaced by large, non-polar groups, that is, radicals containing more than three carbon atoms, exhibit a reverse action in that they exhibit mydriatic and cycloplegic properties.
  • the products of our invention are similar in action to atropine and homatropine.
  • the compounds of our invention have advantages over both atropine and homatropine in that, while the degree of mydriasis and cycloplegia produced by our products is, generally speaking,
  • the compounds mentioned are extremelyhygroscODic so that it is difllcult to ascertain definite melting points therefor.
  • the compounds of the present application have anti-spasmodic action on all types of smooth muscles in human beings.
  • these compounds have extremely low'toxicity per unit of potency, thus 5 making these compounds superior to anti-spasmodic drugs now in general use.
  • compounds of the type listed above, and particularly compounds of the type of the last five listed are more effective,
  • the products of our invention may be obtained by several methods.
  • One such method comprises reacting a tertiary aliphatic'amine as, for instance. trirnethvlamine or tri-ethylam ne, with e-chloro-ethvl-dialkyl carbamate, the alkyl radicals of which contain more than three carbon
  • a tertiary aliphatic'amine as, for instance. trirnethvlamine or tri-ethylam ne
  • e-chloro-ethvl-dialkyl carbamate the alkyl radicals of which contain more than three carbon
  • Example I 50 gms. of 3-chlor-ethyl-chlorcarbonate are dissolved in ether and cooled to 0 C. An ether solution containing 86.5 gms. of di-n-butylamine is added, and the mixture is stirred carefully to maintain-the temperature at 0 C. Ether is used in sufiicient volume to permit
  • di-n-butylamine hydrochloride precipitates, and is filtered oil.
  • the filtrate is extracted with dilute hydrochloric acid to remove any unreacted di-n-butylamine in the form of di-n-butylamine hydrochloride.
  • That fraction is pure p-chlor-ethyl-di-n-butylrcarbamate, a colorless liquid with a refraction index of 1.446-1.448 at 26 C.
  • a 5% aqueous solution of the product has an air-water interfacial tension of approximately 41 dynes/cm. at 25 C.
  • the pH-of aqueous solutions thereof is approximately neutral.
  • Example II after which the tube is cooled to room temperature and opened.
  • the solvent (methyl alcohol) and unreacted triethylamine are removed by evaporation under reduced pressure. After evaporation is completed, two volumes of acetone are added, which results in the precipita tion of a pharmacologically inactive fraction which is removed by filtration. Acetone is evaporated from the filtrate under reduced pressure. Two volumes of ethyl ether are added to the acetone-free residue. and the active principle is extracted with distilled water. Unreacted ,B-chlorethyl ester of di-n-butyl carbamic acid remains in the ether fraction.
  • Example 111 10 arms. of ,q-chlorethyl-chlorcarbonate are mixed with 22.2 gms. of diphenylamine, and refluxed for two hours on a water bath. The solid mixture is then refluxed with 150 cc. of (SO-70 ligroin, and filtered hot to remove diphenylamine hydrochloride. The filtrate is cooledto C., and ,c-chlorethyl-diphenyl-carbamate crystal- It is occurs in the form of white crystals melting at about 72 C.
  • Example IV 32 gms. of p-chlor-isopropyl-chlorcarbonate are dissolved in ethyl ether, and the solution is cooled to 0 C. An ethyl ether solution containing 50 ems. of di-n-butylamine is added, and the mixture is stirred carefully to maintain the temperature at 0 C. Most of the di-n-butylamine hydrochloride formed precipitates, and is filtered off; the filtrate is extracted with dilute hydro-.
  • N -di-n-butyl carbamyl-fl-methylcholine chloride remains as highly hygroscopic, snow-white crystals melting at about 85-105" C.
  • a 7.5% solution of the product in water has an air-water interfacial tension of approximately 42.5 dynes/cm. at 295 C.
  • Example V Di-n-amyl amine hydrochloride is precipitated and filtered oif; the filtrate is extracted with dilute hydrochloric acid to remove any unreacted unreacted c-chlorethyl-di n amyl carbamate.
  • the final product, N-di-n-amyl carba myl choline chloride occurs in the form of highly hygroscopic, snow-white crystals, having a melting point of about 98103 C.
  • An aqueous solution containing 5% of the product has a surface tension of approximately 38.5 dynes/cm. at 29 C. Aqueous solutions thereof have approximately neutral pH.
  • Example VI gms. of ,B-chlorethyl-chlorcarbonate are dissolved in ether, and the solution is cooled to 0 C. An ether solution containing 86.5 gms. of di-isobutylamine is added, and the mixture is stirred carefully to maintain the temperature at 0 C. Most of the di-iso-butylamine hydrochloride precipitates, and is filtered oil; the filtrate is extracted withdilute hydrochloric acid to remove any '1 unreacted di-iso-butylamine (in the form of diiso-butylamine'hydrochloride) The ether and water fractions are separated, and the ether fraction is distilled at atmospheric pressure 1 to remove ether.
  • the vessel is hydrous ether in a dry atmosphere to remove any unreacted s-chlorethyl-di-iso-butyl arbamate.
  • Aqueou Example V1) 7 gms. of di-n-hutyl-carbamylcholine chlori e are dissolved in 50 cc. of distilled water, and 4 gins.
  • Example VIII unreacted fl-chloroethyl-di-n-butyl-carbamate.
  • the ethyl chloride salt of B-dimethylaminoethyldi-n-butylcarbamate (i. e., p-(dimethyl ethyl ammonium chloride) -ethyl-di-n-butyl carbamate) thus obtained is a very highly hygroscopic white crystalline compound.
  • a aqueous solution of this product has an air-water interracial tension of approximately 39 dynes/cm. at 25 C.
  • Th .p-(dimethyl ethyl ammonium sulfate) -ethyl-di-n-butyl carbamate is precipitated from the alcoholic solution by the addition of anhydrous ethyl ether. It ocours in the form of a very hygroscopic white crystalline substance having a melting point of about 166 C. with decomposition.
  • Example IX About 55.5 gms. of s-chloroethyl-di-n-butylcarbamate and about 22.6 gms. of dlmethylamine are placed in a container, firmly sealed, and heated at about 95 C. for about 16 hours. To the resulting crude mixture is added ethyl ether and the mixture filtered to remove dlmethylamine hydrochloride formed during the course of the reaction. The ethereal solution is then extracted with 12 N hydrochloric acid. Under a fresh layer of ether and at a temperature under C. the aqueous acid extract is first neutralized with sodium carbonate and then made strongly alkaline with sodium hydroxide.
  • the supernatant ethereal solution is then separated and dried over potassium hydroxide.
  • the ethereal solution is finally concentrated and the residue obtained is fractionally distilled under vacuum.
  • the fi-dimethylaminoethyl dl n butyl carbamate is found to distill undecomposed at about 128-130 C. under approximately 2 mm. pressure.
  • a mixture of about 100 gms. of p-dimethylaminoethyl-di-n-butyl-carbamate and about 188 cc. of ethyl iodide is held at about C. for two hours. The temperature is kept about 25 C. by occasional cooling in an ice bath during the first half hour. About 1600 cc. of anhydrous ethyl ether is then added'causlng the precipitation of a dense white product. After standing for about 16 hours at 0 C. the product is filtered off, washed thoroughly with anhydrous ether, and dried under diminished pressure at room temperature over sulfuric acid.
  • the p-(dimethyl ethyl ammonium iodide) -ethyl-di-n-butyl carbamate thus obtained is a white crystalline powder, slightly hygroscopic with a melting point of about 76-77 C.
  • Example X A quantity of p-dirnethylamino ethyl di-n-butyl carbamate, prepared as in Example IX above, is dissolved in anhydrous ethyl ether, and dry hydrogen chloride gas in excess of that theoretically required to form the hydrochloride salt is passed through the mixture. Ether is then removed by evaporation and the residue is extracted with cold acetone by thorough trituration. The acetone extract is then filtered, partially evaporated, and the product, p-(dimethyl ammonium chloride)- ethyl-dl-n-butyl carbamate is precipitated by addition of anhydrous ethyl ether. 1
  • Example XI A mixture of about 150 gms. or ,B-(dimethyl ethyl ammonia iodide) -ethyl-di-n-butyl carbonate, gms. of silver sulfate, 750 cc. of water and 750 cc. of ethanol is stirred at about 30 C. for approximately 45 minutes. The silver iodide formed is removed and the excess silver remaining in solution is removed by bubbling in hydrogen sulfide for five minutes followed by filtration to remove the precipitated silver sulfide. The filtrate is concentrated to a thick syrup under vacuum and about one liter of benzene is added which is distilled 011 with stirring at atmospheric pressure to remove the last traces of water.
  • the residual benzene is removed under vacuum and the product granulated by stirring with one liter of anhydrous ether for two hours. The product is removed, washed with anhydrous ether, and dried under dlrninished pressure over phosphorous pentoxide at 25 C.
  • the p-(dimethyl ethyl ammonium sulfate) ethyl-di-n- 'butyl carbamate thus obtained is a very hygroscopic white solid having a melting point of about 166 C. with decomposition.
  • Example XIII A mixture of about 10 gms. of p-dimethylaminoethyl-di-n-butyl-carbamate and about 18 cc. of ethyl bromide is refluxed for approximately four hours. To the resulting solution is added about cc. of anhydrous ethyl ether, causing precipitation of the fi-(dimethyl ethyl ammonium bromide) ethyl-di-n-butyl carbamate which is removed by filtration. This product, purified by recrystallization from carbon tetrachloride, has a melting point of about 45-47 C.
  • Example XIII A mixture of about 10 gms. of p-dimethylaminoethyl di-n-butyl-carbamate, about 12.6 gms. of diethyl sulfate. and 50 cc. of anhydrous ethyl ether is refluxed overnight.
  • the e-(dimethyl ethyl ammonium ethyl-suliate)-ethyldi-n-butyl carbamate precipitates on standing, is filtered, and washed with ethyl ether, and recrystallized from 50 cc. 01' carbon tetrachloride.
  • the recrystallized material has a melting point of about ZS-805 C.
  • Example XIV About 23.5 gms. of p-chloroethyl-di-n-butyl carbamate and about 14.6 gms. of diethylamine are placed in a container capable oi. being tightly closed and heated for about twelve hours, at 110 C. The container is then cooled and opened and the mixture is transferred into about 300 cc. of anhydrous ether. Dry hydrogen chloride gas in excess of that required to react with a 100% theoretical yield of tertiary amine is passed through the mixture. The ether is then removed by evaporation and the resulting mass is extracted with about 100 cc. of cold acetone by thorough trituration. After filtering of!

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

Patented Dec. 2, 1947 UNITED STATES PATENT OFFICE CHOLINELIKE COMPOUNDS Kenneth 0. Swan, Portland, reg., and Norman G. White, Craniord, N. J.
No Drawing. Application August 31, 1945, Serial No. 613,964
8 Claims. (91. 260-482) This application is a our copending application Serial No. 497,858 filed August 7, 1943 (issued as U. S. Patent No. 2,408,- 893 on October 8, 1946), relating to a new class of carbamic acid esters of compounds of the choline type, which substances exhibit valuable pharmacological properties. The compounds of said copending application may be represented by the formula:
wherein R is selected from the group consisting of lower alkyl radicals; X is an anion; R is selected from the group consisting of hydrogen and lower alkyl radicals; and R" is selected from the wherein'the substituents R. are the same and of the class consisting of lower alkyl'radicals, R1 is of the class consisting of H and lower alkyl radicals different from the substituents R, R2 is of the class consisting of alkyl radicals of at least four carbon atoms and aryl radicals, R3 is of the class consisting of H and lower alkyl radicals, and X is an anion.
We have found that, whereas other compounds of the choline series, such as acetylcholine chloride, and carbaminoyl choline chloride, and
derivatives in which the hydrogens attached to the nitrogen of the carbamate group are recontinuation-in-part of i placed by small polar groups, that is, radicals containing less than four carbon atoms, produce constriction of the pupil and contraction of the ciliary muscle when administered to individuals, the compounds of our invention, in which the hydrogens attached to the nitrogen of the carbamate group are replaced by large, non-polar groups, that is, radicals containing more than three carbon atoms, exhibit a reverse action in that they exhibit mydriatic and cycloplegic properties.
While we do not wish to commit ourselves to any definite theory as to the cause of the reversal of activity experienced with our new products, in which highly hydrophilic choline salts are combined by an ester linkage with highly hydrophobic groups, it appears that the unexpected properties exhibited by the compounds of our invention may be due to the fact that the elongated molecules which are predominantly hydrophilic at the choline end, and predominantly hydrophobic at the opposite end, are surface-active, and that such surface activity not only enables the compounds to penetrate the cornea of the eye more readily, but also causes the differences in pharmacological effects due to the difierences in site of action on the cell.
The products of our invention are similar in action to atropine and homatropine. However, the compounds of our invention have advantages over both atropine and homatropine in that, while the degree of mydriasis and cycloplegia produced by our products is, generally speaking,
of the 'same order as that of atropine and homatropine', we have found that where our products? have been administered, cycloplegia, and particularly mydriasis, are markedly less prolonged, resulting in a shorter period of visual disability than is experienced in the case of atropine or ,homatro,pine. Further, the products of our invention do not produce the marked liyperemia and irritation of the conjunctiva which are incidental to the use of homatropine in many cases. The products of our invention have antiseptic properties.
3 Among the compounds which fall within the purview of our invention may be mentioned the following representative substances:
triethyl amp-(Dimethyl ethyl ammonium sulfate)-ethyldi-n-butyI carbamate M. P. about l65-l66 C. (dec.) fi-(Dimethyl ethyl ammonium-ethyl-sulfate)- ethyl-di-n-butyl carbamate M. P. '78-80.5 C. fl-(Dimethyl ethyl ammonium iodide) -ethyldi-n-butyl carbamate M. P. 76-77 C.
fi-(Dimethyl ethyl ammonium bromide) -ethyldi-n-butyl carbamate M. PAS-47 C. [1- (Dimethyl ammonium chloride) -ethyl-di-nbutyl carbamate M. P. 90-90.5 C.
In most instances, the compounds mentioned are extremelyhygroscODic so that it is difllcult to ascertain definite melting points therefor.
These new compounds are very valuable for amination and cycloplegic refraction.
clinical application in routine intraocular ex- For example, we have found that two instillations of a 7.5% aqueous solution of N-di-n-butyl carbamyl choline sulfate into the conjunctival sac produce mydriasis and cycloplegia beginning within twenty minutes and becoming maximal in 60-90 minutes, the reactions of the intraocular muscles usually returning to normal in about 7-12 hours after administration of the substance.
In addition to being valuable mydriatic and cycloplegic drugs, the compounds of the present application have anti-spasmodic action on all types of smooth muscles in human beings. As anti-spasmodic drugs, these compounds have extremely low'toxicity per unit of potency, thus 5 making these compounds superior to anti-spasmodic drugs now in general use. For example, in relaxation of the ureter, compounds of the type listed above, and particularly compounds of the type of the last five listed, are more effective,
and produce fewer side effects, than drugs normally employed for this relief. For optical application to produce mydriasis and cycloplegia, compounds which are salts of e-(dimethyl ethyl ammonium) -ethyl-di-n -butyl carbamate are preferred compounds, and the ammonium sulfate salt is the most suitable compound because of the extremely low conjunctiva] irritation produced.
The products of our invention may be obtained by several methods. One such method comprises reacting a tertiary aliphatic'amine as, for instance. trirnethvlamine or tri-ethylam ne, with e-chloro-ethvl-dialkyl carbamate, the alkyl radicals of which contain more than three carbon Example I 50 gms. of 3-chlor-ethyl-chlorcarbonate are dissolved in ether and cooled to 0 C. An ether solution containing 86.5 gms. of di-n-butylamine is added, and the mixture is stirred carefully to maintain-the temperature at 0 C. Ether is used in sufiicient volume to permit adequate mixing. Most of the di-n-butylamine hydrochloride precipitates, and is filtered oil. The filtrate is extracted with dilute hydrochloric acid to remove any unreacted di-n-butylamine in the form of di-n-butylamine hydrochloride.
The ether and water fractions are separated,
and the ether fraction is distilled at atmospheric pressure to remove ether. The residue is then distilled under reduced pressure and the fraction boiling at 151152 C./l8 mm. (uncorrected) is collected as one fraction. That fraction is pure p-chlor-ethyl-di-n-butylrcarbamate, a colorless liquid with a refraction index of 1.446-1.448 at 26 C.
21 gms. of p-chlorethy'l-di-n-butyl-carbamate and 6 gms. of condensed trimethylamine are placed in a vessel, and the vessel is closed firmly and maintained at C. A white, crystalline solid forms. After 18 hours, the vessel is opened and placed in vacuo to remove any unreacted trimethylamine. The final product is washed with anhydrous ether in a dry atmosphere to remove any unreacted p-chlorethyl-di-n-butylcarbamate. N-di-n-butyl carbamyl choline chloride occurs as a highly hygroscopic, snow-white crystalline compound, melting at about 98-110 C.
A 5% aqueous solution of the product has an air-water interfacial tension of approximately 41 dynes/cm. at 25 C. The pH-of aqueous solutions thereof is approximately neutral.
Example II after which the tube is cooled to room temperature and opened. The solvent (methyl alcohol) and unreacted triethylamine are removed by evaporation under reduced pressure. After evaporation is completed, two volumes of acetone are added, which results in the precipita tion of a pharmacologically inactive fraction which is removed by filtration. Acetone is evaporated from the filtrate under reduced pressure. Two volumes of ethyl ether are added to the acetone-free residue. and the active principle is extracted with distilled water. Unreacted ,B-chlorethyl ester of di-n-butyl carbamic acid remains in the ether fraction. When the water is evaporated under reduced pressure, the product, B-N-di-n-butyl carbamylethyl triethyl ammonium chloride remains in the form of white, hygroscopic crystals melting at about 68-89 C. A 7% aqueous solution of the product has an lizes out and is separated by filtration. then recrystallized from 60 ligroin. The product air-water interfacial tension of approximately 42.0 dynes/cm. at 39 C.
Example 111 10 arms. of ,q-chlorethyl-chlorcarbonate are mixed with 22.2 gms. of diphenylamine, and refluxed for two hours on a water bath. The solid mixture is then refluxed with 150 cc. of (SO-70 ligroin, and filtered hot to remove diphenylamine hydrochloride. The filtrate is cooledto C., and ,c-chlorethyl-diphenyl-carbamate crystal- It is occurs in the form of white crystals melting at about 72 C.
14 gms. of {i-chlorethyl-diphenyl-carbamate are placed in a container with gms. of a trimethylamine solution in absolute-alcohol. The container is closed firmly and heated at 85 C. for 16 hours. The solution is then cooled to 0 C.
- and 6 gms. of condensed trimethylamine are placed in a vessel, and the vessel is closed firmly and maintained at 85 C. A white crystalline solid forms. After 18 hours, the vessel is opened and placed in vacuo to remove any unreacted trimethylamine. The residue is washed with anhydrous ether in a dry atmosphere to remove any and N-diphenyl-carbamylchlorine chloride is precipitated by the addition of acetone. The product is recrystallized from acetone. It occurs in the form of non-hygroscopic, snow-white crystals melting at about 204 C. (uncorrected). soluble in water and alcoholy-slightly soluble in acetone.
Example IV 32 gms. of p-chlor-isopropyl-chlorcarbonate are dissolved in ethyl ether, and the solution is cooled to 0 C. An ethyl ether solution containing 50 ems. of di-n-butylamine is added, and the mixture is stirred carefully to maintain the temperature at 0 C. Most of the di-n-butylamine hydrochloride formed precipitates, and is filtered off; the filtrate is extracted with dilute hydro-.
chloric acid to remove any unreacted di-n-butylamine in the form of di-n-butylamine hydrochloride. The ether and water fractions are sep- It is arated, and the ether fractipn is distilled at atmospheric pressure to remove ether. The residue is then distilled under reduced pressure, and the fraction boiling at 158-159? C./20 mm. (uncorrected) is collected as one fraction. That fraction is pure fl-chlorisopropyl-di-n butyl-carbamate, a colorless liquid with a refractive index of about 1.446 at 26 C.
21 gms. of p-chlor-isopropyl-di-n-butyl carbamate and 20 gms. of 30% (by weight) trimethylamine in absolute ethyl alcohol are placed in a vessel. The vessel is firmly closed, and maintained at 105 C. After 18 hours, the vessel is opened in a dry atmosphere and placed in vacuo to remove any unreacted trimethylaminc; Ethyl ether is added to the residue, and the product is extracted with distilled water. After the water is removed in vacuo over P205, the final product, N -di-n-butyl carbamyl-fl-methylcholine chloride, remains as highly hygroscopic, snow-white crystals melting at about 85-105" C. A 7.5% solution of the product in water has an air-water interfacial tension of approximately 42.5 dynes/cm. at 295 C. I
Example V -Di-n-amyl amine hydrochloride is precipitated and filtered oif; the filtrate is extracted with dilute hydrochloric acid to remove any unreacted unreacted c-chlorethyl-di n amyl carbamate. The final product, N-di-n-amyl carba myl choline chloride, occurs in the form of highly hygroscopic, snow-white crystals, having a melting point of about 98103 C. An aqueous solution containing 5% of the product has a surface tension of approximately 38.5 dynes/cm. at 29 C. Aqueous solutions thereof have approximately neutral pH.
Example VI gms. of ,B-chlorethyl-chlorcarbonate are dissolved in ether, and the solution is cooled to 0 C. An ether solution containing 86.5 gms. of di-isobutylamine is added, and the mixture is stirred carefully to maintain the temperature at 0 C. Most of the di-iso-butylamine hydrochloride precipitates, and is filtered oil; the filtrate is extracted withdilute hydrochloric acid to remove any '1 unreacted di-iso-butylamine (in the form of diiso-butylamine'hydrochloride) The ether and water fractions are separated, and the ether fraction is distilled at atmospheric pressure 1 to remove ether. distilled under reduced pressure, and the fraction boiling at 144-146 C./20 mm. (uncorrected) is collected as one fraction. That fraction is pure p-chlorethyl-di-isobutyl-carbamate, a colorless liquid with a refraction index of 1.4464448 at The residue is then 21 gms. of ,8-chlorethyl-di-iso-butyl-carbamate and 6 gms. of condensed trimethylamine are i solutions thereof have approximately neutral p placed in a vessel, and the vessel is firmly closed and maintained at C. A white, crystalline solid forms. After 18 hours, the vessel is hydrous ether in a dry atmosphere to remove any unreacted s-chlorethyl-di-iso-butyl arbamate. The final product, N-di-iso-butyl carliamyl cho- 5 line chloride, occurs in the form of highly hygroscopic, snow-White crystals, melting at about 147-148" C. A 5% 1 proximately 41.5"dynes/cm..at 29.5 C. Aqueou Example V1) 7 gms. of di-n-hutyl-carbamylcholine chlori e are dissolved in 50 cc. of distilled water, and 4 gins. of finely powdered silver sulfate are added. The vessel is sealed, and shaken at room temperature until a filtered sample does not yield a precipitate when silver nitrate is added. The mixture is then filtered to remove precipitated silver chloride. The filtrate is dried in vacuo. and the residue is extracted with anhydrous ethyl alcohol. N-di n butyl carbamyl choline sulfate is opened, and placed in vacuo to remove any unreacted j trimethylamine. The product is washed with anprecipitated from the alcohol solution by addition of anhydrous ethyl ether. It occurs in the form of slightly hygroscopic, white crystals melting at about 198-200 C. A 7.5% aqueous solution thereof has an air-water interracial tension of 39-40 dynes/cm. at 29 C.
Example VIII unreacted fl-chloroethyl-di-n-butyl-carbamate.
The ethyl chloride salt of B-dimethylaminoethyldi-n-butylcarbamate (i. e., p-(dimethyl ethyl ammonium chloride) -ethyl-di-n-butyl carbamate) thus obtained is a very highly hygroscopic white crystalline compound. A aqueous solution of this product has an air-water interracial tension of approximately 39 dynes/cm. at 25 C.
About 7 gms. of the fl-(dimethyl ethyl ammo-- nium chloride)-ethy1-di-n-butyl carbamate is dissolved in about 50 cc. of distilled water and about 4 gms. of finely powdered silver sulfate is added. The vessel is sealed and shaken at room temperature until a filtered sample does not yield a precipitate when silver nitrate is added. The mixture is then filtered to remove the precipitated silver chloride. The filtrate is dried under diminished pressure and the residue extracted with anhydrous ethyl alcohol. Th .p-(dimethyl ethyl ammonium sulfate) -ethyl-di-n-butyl carbamate is precipitated from the alcoholic solution by the addition of anhydrous ethyl ether. It ocours in the form of a very hygroscopic white crystalline substance having a melting point of about 166 C. with decomposition.
Example IX About 55.5 gms. of s-chloroethyl-di-n-butylcarbamate and about 22.6 gms. of dlmethylamine are placed in a container, firmly sealed, and heated at about 95 C. for about 16 hours. To the resulting crude mixture is added ethyl ether and the mixture filtered to remove dlmethylamine hydrochloride formed during the course of the reaction. The ethereal solution is then extracted with 12 N hydrochloric acid. Under a fresh layer of ether and at a temperature under C. the aqueous acid extract is first neutralized with sodium carbonate and then made strongly alkaline with sodium hydroxide. The supernatant ethereal solution is then separated and dried over potassium hydroxide. The ethereal solution is finally concentrated and the residue obtained is fractionally distilled under vacuum. The fi-dimethylaminoethyl dl n butyl carbamate is found to distill undecomposed at about 128-130 C. under approximately 2 mm. pressure.
A mixture of about 100 gms. of p-dimethylaminoethyl-di-n-butyl-carbamate and about 188 cc. of ethyl iodide is held at about C. for two hours. The temperature is kept about 25 C. by occasional cooling in an ice bath during the first half hour. About 1600 cc. of anhydrous ethyl ether is then added'causlng the precipitation of a dense white product. After standing for about 16 hours at 0 C. the product is filtered off, washed thoroughly with anhydrous ether, and dried under diminished pressure at room temperature over sulfuric acid. The p-(dimethyl ethyl ammonium iodide) -ethyl-di-n-butyl carbamate thus obtained is a white crystalline powder, slightly hygroscopic with a melting point of about 76-77 C.
By reacting fi-chloroethyl-di-n-butyl carbamate withdiethylamine and thenreacting the intermediate p-diethylaminoethyl di n butyl carbamate with methyl iodide, according to the foregoing procedure, B-(diethyl methyl ammonium iodide) ethyl di-n-butyl carbamate is obtained.
Example X A quantity of p-dirnethylamino ethyl di-n-butyl carbamate, prepared as in Example IX above, is dissolved in anhydrous ethyl ether, and dry hydrogen chloride gas in excess of that theoretically required to form the hydrochloride salt is passed through the mixture. Ether is then removed by evaporation and the residue is extracted with cold acetone by thorough trituration. The acetone extract is then filtered, partially evaporated, and the product, p-(dimethyl ammonium chloride)- ethyl-dl-n-butyl carbamate is precipitated by addition of anhydrous ethyl ether. 1
Example XI A mixture of about 150 gms. or ,B-(dimethyl ethyl ammonia iodide) -ethyl-di-n-butyl carbonate, gms. of silver sulfate, 750 cc. of water and 750 cc. of ethanol is stirred at about 30 C. for approximately 45 minutes. The silver iodide formed is removed and the excess silver remaining in solution is removed by bubbling in hydrogen sulfide for five minutes followed by filtration to remove the precipitated silver sulfide. The filtrate is concentrated to a thick syrup under vacuum and about one liter of benzene is added which is distilled 011 with stirring at atmospheric pressure to remove the last traces of water. The residual benzene is removed under vacuum and the product granulated by stirring with one liter of anhydrous ether for two hours. The product is removed, washed with anhydrous ether, and dried under dlrninished pressure over phosphorous pentoxide at 25 C. The p-(dimethyl ethyl ammonium sulfate) ethyl-di-n- 'butyl carbamate thus obtained is a very hygroscopic white solid having a melting point of about 166 C. with decomposition.
Example XIII A mixture of about 10 gms. of p-dimethylaminoethyl-di-n-butyl-carbamate and about 18 cc. of ethyl bromide is refluxed for approximately four hours. To the resulting solution is added about cc. of anhydrous ethyl ether, causing precipitation of the fi-(dimethyl ethyl ammonium bromide) ethyl-di-n-butyl carbamate which is removed by filtration. This product, purified by recrystallization from carbon tetrachloride, has a melting point of about 45-47 C.
Example XIII A mixture of about 10 gms. of p-dimethylaminoethyl di-n-butyl-carbamate, about 12.6 gms. of diethyl sulfate. and 50 cc. of anhydrous ethyl ether is refluxed overnight. The e-(dimethyl ethyl ammonium ethyl-suliate)-ethyldi-n-butyl carbamate precipitates on standing, is filtered, and washed with ethyl ether, and recrystallized from 50 cc. 01' carbon tetrachloride. The recrystallized material has a melting point of about ZS-805 C.
Example XIV About 23.5 gms. of p-chloroethyl-di-n-butyl carbamate and about 14.6 gms. of diethylamine are placed in a container capable oi. being tightly closed and heated for about twelve hours, at 110 C. The container is then cooled and opened and the mixture is transferred into about 300 cc. of anhydrous ether. Dry hydrogen chloride gas in excess of that required to react with a 100% theoretical yield of tertiary amine is passed through the mixture. The ether is then removed by evaporation and the resulting mass is extracted with about 100 cc. of cold acetone by thorough trituration. After filtering of! the acetone extract, the acetone is evaporated until a precipitate begins to form. Acetone, Just sumcient for complete solution, is then added and to this solution is added anhydrous ethyl ether causing precipitation of p-(diethyl ammonium chloride) ethyl-di-n-butyl carbamate. This product is obtained as fine, snow-white, slightly hygroscopic crystals melting at about 90-90.5 C.
Modifications may be made in carrying out the present invention without departing from the spirit and scope thereof, and the invention is to be limited only by the appended claims.
What is claimed is:
1. An essentially non-toxic surface-active com- P und of the formula wherein the substituents R are the same and of the class consisting of methyl and ethyl radicals, R1 is different from the substituents R and of the class consisting of H and methyl and ethyl radicals, R2 is of the class consisting of alkyl radicals of at least four carbon atoms and the phenyl radical, R: is of the class consisting of H and methyl radicals and X is an anion.
2. An essentially non-toxic surface-active com pound of the formula wherein X is an anion.
1 0 3. An essentially non-toxic surface-active compound or the formula wherein X is halogen.
4. An essentially non-toxic surface-active compound of the formula n-butyl n-butyl wherein R is of the class consisting of methyl and ethyl radicals and X is halogen.
6. p-(Dimethyl ethyl ammonium ethyl-di-n-butyl carbamate.
7. QJDimethyI ethyl ammonium sulfate)- ethyl-di-n-butyl carbamate.
8. p-(Diethyl ammonium chloride) -ethyl-din-butyl carbamate.
iodide) KENNETH C. SWAN. NORMAN G. WHITE.
REFERENCES CITED The following references are of record in the file of this patent:
UNITED STATES PATENTS Number Name Date 2,109,492 Lott et al. Mar. 1, 1938 I 2,137,042 Christiansen et al. Nov. 15, 1938 OTHER REFERENCES A. c. a," vol. 63, (1941), p
US613964A 1945-08-31 1945-08-31 Cholinelike compounds Expired - Lifetime US2432049A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US613964A US2432049A (en) 1945-08-31 1945-08-31 Cholinelike compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US613964A US2432049A (en) 1945-08-31 1945-08-31 Cholinelike compounds

Publications (1)

Publication Number Publication Date
US2432049A true US2432049A (en) 1947-12-02

Family

ID=24459365

Family Applications (1)

Application Number Title Priority Date Filing Date
US613964A Expired - Lifetime US2432049A (en) 1945-08-31 1945-08-31 Cholinelike compounds

Country Status (1)

Country Link
US (1) US2432049A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2556146A (en) * 1948-11-05 1951-06-05 Gen Aniline & Film Corp Di-(beta-hydroxyalkyl)-2-(alkyl carbamyl-oxy)- alkylamines
US2585826A (en) * 1948-11-05 1952-02-12 Gen Aniline & Film Corp Carbamate-quaternary ammonium compounds and their preparation
US2604449A (en) * 1949-03-08 1952-07-22 Swan Finch Oil Corp Greases and compounds for making same and other compositions
US2794810A (en) * 1952-03-08 1957-06-04 Searle & Co Aminoalkyl cycloalkylcarbamates
US2885433A (en) * 1954-08-19 1959-05-05 Lab Francais Chimiotherapie O-carbamyl-d-serine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2109492A (en) * 1933-08-30 1938-03-01 Squibb & Sons Inc Carbanilic acid derivatives
US2137042A (en) * 1937-09-09 1938-11-15 Squibb & Sons Inc Carbanilic acid esters of substituted alkylaminoalkanols

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2109492A (en) * 1933-08-30 1938-03-01 Squibb & Sons Inc Carbanilic acid derivatives
US2137042A (en) * 1937-09-09 1938-11-15 Squibb & Sons Inc Carbanilic acid esters of substituted alkylaminoalkanols

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2556146A (en) * 1948-11-05 1951-06-05 Gen Aniline & Film Corp Di-(beta-hydroxyalkyl)-2-(alkyl carbamyl-oxy)- alkylamines
US2585826A (en) * 1948-11-05 1952-02-12 Gen Aniline & Film Corp Carbamate-quaternary ammonium compounds and their preparation
US2604449A (en) * 1949-03-08 1952-07-22 Swan Finch Oil Corp Greases and compounds for making same and other compositions
US2794810A (en) * 1952-03-08 1957-06-04 Searle & Co Aminoalkyl cycloalkylcarbamates
US2885433A (en) * 1954-08-19 1959-05-05 Lab Francais Chimiotherapie O-carbamyl-d-serine

Similar Documents

Publication Publication Date Title
DE1670536B2 (en) New 2-anilino-5-acylamino-pyrimidlne
US2432049A (en) Cholinelike compounds
EP0043940A1 (en) 3,1-Benzoxazin-2-ones, their preparation and their use
DE2438399C3 (en) α-substituted benzhydrol derivatives and their salts, medicaments containing them and processes for the preparation thereof
US2408893A (en) Choline-like compounds
DD284026A5 (en) METHOD FOR THE PRODUCTION OF ESTERS
EP0256258A2 (en) Salts of methoxyphenyl-dimethylaminomethyl-cyclohexanol, medicaments containing these and process for their preparation
US2648710A (en) Bis-quaternary salts of 1:10-bis-(dialkylamino)-5:6-dithia-decane
US3271248A (en) Pharmaceutical compositions containing amine mercapto-succinates
DE2923698A1 (en) SUBSTITUTED AMINO ALKANIC ACIDS, THEIR USE AND PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THEM
DE2729165A1 (en) NEW DERIVATIVES OF PHENAETHYLAMINE, THEIR SALTS, METHOD FOR THE PRODUCTION THEREOF AND THEIR PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US2878279A (en) Process of making bis-carbamic acid ester compounds
DD275689A5 (en) PROCESS FOR THE PREPARATION OF ENOLETHERS OF 6-CHLORO-4-HYDROXY-2-METHYL-N- (2-PYRIDYL) -2H-THIENO (2,3-E) -1,2-THIAZINE-3-CARBONSAFEAMIDE-1,1 dioxide
DE2122070A1 (en) 1 Veratryl 4 methyl 5 ethyl 7,8 dimethoxy 2,3 diazabicyclo square brackets to 5,4,0 square brackets to undeca pentaen (1,3,6,8,10) and its use
US3308019A (en) Alkyl-n-[alpha, alpha-dimethyl-beta-(p-halophenyl)-ethyl]-carbamates and compositions thereof
DE2725245A1 (en) METHYLAMINE DERIVATIVES, THE PROCESS FOR THEIR PRODUCTION AND THE PHARMACEUTICAL OR VETERINARY MEDICAL COMPOSITIONS THEREOF
EP0069894B1 (en) Optically active dipeptides, pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions containing them
US2855401A (en) Certain n-(aminophenoxy pentyl) sulfonamide or saccharine compounds and higher homologues
DE2738498A1 (en) NEW NITROSOURA DERIVATIVES
DE936268C (en) Process for the preparation of new N-methyl-trimethyl-colchicine amides and their salts
DE537188C (en) Process for the preparation of aminoketo alcohols
DE2408372A1 (en) PHARMACEUTICAL PREPARATIONS ON THE BASIS OF HIPPURIC ACID DERIVATIVES
US2786841A (en) Barbituric acid product
DE1768505B2 (en) Phenethylamine compounds and processes for their production
EP0284892B1 (en) Thienyloxyacetic acid derivatives, a process for their preparation, and pharmaceutical compositions containing them